Nuveen’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $6.17M | Buy |
423,050
+3,600
| +0.9% | +$34.7K | ﹤0.01% | 1972 |
|
|
2026
Q1 | $3.11M | Sell |
419,450
-4,143
| -1% | -$43.6K | ﹤0.01% | 2092 |
|
|
2025
Q4 | $4.98M | Sell |
423,593
-285,578
| -40% | -$3.08M | ﹤0.01% | 1907 |
|
|
2025
Q3 | $5.47M | Buy |
709,171
+284,088
| +67% | +$1.99M | ﹤0.01% | 1868 |
|
|
2025
Q2 | $3.11M | Buy |
425,083
+79,393
| +23% | +$641K | ﹤0.01% | 2105 |
|
|
2025
Q1 | $3.28M | Buy |
345,690
+23
| +0% | +$287 | ﹤0.01% | 2130 |
|
|
2024
Q4 | $5.7M | Sell |
345,667
-98,179
| -22% | -$1.52M | ﹤0.01% | 1922 |
|
|
2024
Q3 | $6.55M | Buy |
443,846
+1,096
| +0.2% | +$17.1K | ﹤0.01% | 1860 |
|
|
2024
Q2 | $6.14M | Sell |
442,750
-177,521
| -29% | -$2.52M | ﹤0.01% | 1843 |
|
|
2024
Q1 | $9.75M | Sell |
620,271
-127,382
| -17% | -$1.97M | ﹤0.01% | 1601 |
|
|
2023
Q4 | $12.1M | Sell |
747,653
-59,095
| -7% | -$967K | ﹤0.01% | 1470 |
|
|
2023
Q3 | $9.92M | Sell |
806,748
-587
| -0.1% | -$8.73K | ﹤0.01% | 1491 |
|
|
2023
Q2 | $13M | Buy |
807,335
+48,670
| +6% | +$802K | ﹤0.01% | 1346 |
|
|
2023
Q1 | $13.2M | Sell |
758,665
-149,521
| -16% | -$2.13M | ﹤0.01% | 1303 |
|
|
2022
Q4 | $8.39M | Buy |
908,186
+342,326
| +60% | +$3.19M | ﹤0.01% | 1609 |
|
|
2022
Q3 | $4.87M | Sell |
565,860
-482,110
| -46% | -$4.79M | ﹤0.01% | 1919 |
|
|
2022
Q2 | $8.54M | Buy |
1,047,970
+379,580
| +57% | +$3.62M | ﹤0.01% | 1618 |
|
|
2022
Q1 | $11.5M | Sell |
668,390
-21,177
| -3% | -$446K | ﹤0.01% | 1554 |
|
|
2021
Q4 | $23.5M | Sell |
689,567
-59,934
| -8% | -$2.35M | 0.01% | 1119 |
|
|
2021
Q3 | $36.2M | Sell |
749,501
-142,178
| -16% | -$6.58M | 0.01% | 867 |
|
|
2021
Q2 | $40.3M | Buy |
891,679
+8,027
| +0.9% | +$356K | 0.01% | 871 |
|
|
2021
Q1 | $42.6M | Buy |
883,652
+104,285
| +13% | +$5.43M | 0.01% | 808 |
|
|
2020
Q4 | $42M | Buy |
779,367
+74,693
| +11% | +$3.38M | 0.01% | 792 |
|
|
2020
Q3 | $26M | Buy |
704,674
+40,493
| +6% | +$1.51M | 0.01% | 912 |
|
|
2020
Q2 | $20.6M | Sell |
664,181
-503,256
| -43% | -$13.9M | 0.01% | 1030 |
|
|
2020
Q1 | $32.2M | Buy |
1,167,437
+77,113
| +7% | +$2.31M | 0.02% | 651 |
|
|
2019
Q4 | $31.9M | Sell |
1,090,324
-47,437
| -4% | -$1.13M | 0.01% | 912 |
|
|
2019
Q3 | $21.8M | Buy |
1,137,761
+227,756
| +25% | +$5.34M | 0.01% | 1077 |
|
|
2019
Q2 | $20M | Buy |
+910,005
| New | +$20M | 0.01% | 1153 |
|
Other funds holding NEO
FLAM
GF
NAMI
B
Nuveen's NEO Position: Q2 2026 in Review
Nuveen increased its NeoGenomics (NEO) stake by 0.86% in Q2 2026, buying an estimated $34.7K and bringing the position to 423,050 shares worth $6.17M. The position accounts for ﹤0.01% of the portfolio, ranked #1972.
Nuveen first reported a position in NEO in Q2 2019 and has held it in 29 quarters since. The position peaked at $42.6M in Q1 2021. 266 funds tracked by Wall St. Rank hold NEO as of Q2 2026.
- Nuveen held 423,050 shares of NeoGenomics worth $6.17M as of Q2 2026.
- Nuveen bought 3,600 NeoGenomics shares in Q2 2026, an estimated $34.7K.
- NeoGenomics made up ﹤0.01% of Nuveen's portfolio in Q2 2026, its #1972 holding.
- Nuveen first reported a position in NeoGenomics in Q2 2019 and has held it in 29 quarters since.
- Nuveen's NeoGenomics position peaked at $42.6M in Q1 2021.
- 266 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.
Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.